Asia Pacific Infertility Diagnostics Devices Market Report and Forecast 2024-2032

Asia Pacific Infertility Diagnostics Devices Market Outlook

The global infertility diagnostics market size is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with Asia-Pacific having a significant contribution to market growth. The market is driven by the increasing prevalence of infertility in the region.

Key Takeaways

• According to a white paper released by Ferring Pharmaceuticals in November 2023, major Asian countries such as Singapore, Japan, and Taiwan, led by South Korea, are experiencing an unparalleled decrease in fertility.

• One of the major Asia Pacific infertility diagnostics devices market trends includes noteworthy innovations and product launches for infertility diagnosis. In December 2023, Arva Health launched a new diagnostic tool targeting Indian women with health concerns such as PCOS and thyroid to track their reproductive health.

• Government funding activities are impacting the infertility diagnostics devices market in the Asia Pacific region. For instance, the Mechanobiology Institute (MBI) at the National University of Singapore received a funding of around USD 36 million for innovating age-related conditions including infertility.

Asia Pacific Infertility Diagnostics Devices Market Analysis

In the Asia Pacific region, infertility is on the rise, which can be attributed to evolving lifestyle of the population. Unhealthy dietary habits, substance indulgence, deterioration of work life balance, and a sedentary lifestyle are amongst major causes for the condition. In November 2023, Ferring Pharmaceuticals surveyed 7 major regions of Asia to determine the decline in fertility rates, and to educate people about the importance of being aware of the availability of diagnostic facilities. The data registered through the survey showcased an unparalleled decline in fertility rates in the region, with major countries like South Korea, Japan and Singapore leading the charts. This decline in fertility rates is driving the Asia Pacific infertility diagnostics devices market share.

The market is further driven by the rise in the awareness initiatives to normalise infertility diagnostic tests. The government, along with non-profit organisations are setting up various awareness campaigns while also providing national financial coverage schemes for the same. The trend is noticeable in several emerging economies such as Singapore, Japan, South Korea, Indonesia, and Taiwan among others.

To meet the rising Asia Pacific infertility diagnostics devices market demand, there has been an influx of new product launches by market players significantly influencing the market growth. These new launches are personalised and provide insightful data about women's reproductive health, helpful in understanding how their fertility health is influenced by their lifestyle choices. For instance, in December 2023, an Indian health-tech company, Arva Health launched its at-home fertility test especially curated for Indian women suffering from PCOS and thyroid issues. The company aims to provide unprecedented insights to women about their reproductive hormones in comprehensive language including tests like anti-mullerian hormone AMH and Ovarian Reserve.

The Asia Pacific infertility diagnostics devices market growth is further fuelled by government funding for research and development of novel technologies and therapeutics for treating infertility.  For instance, in January 2024, the National Research Foundation (NRF) offered a funding of SGD 49 million (nearly USD 36 million) to National University of Singapore (NUS) affiliated Mechanobiology Institute (MBI). The funding enables the scientists to explore and research on various aspects of human health and focus on developing more effective diagnostics for diseases as well. It marks a significant initiative to improve the healthcare infrastructure and incorporate latest research equipment in the region as well.

Asia Pacific Infertility Diagnostics Devices Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Asia Pacific Infertility Diagnostics Devices Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cook Group

• Vitrolife

• Thermo Fisher Scientific

• Hamilton Thorne LTD

• Esco Micro Pte Ltd

• Genea Limited

• IVFtech APS

• FIJIFILM Irvine Scientific

• The Baker Company INC

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report